Price list of cabozantinib targeted drugs

Cabozantinib (Cabozantinib) is a targeted therapy drug that belongs to the category of multi-target tyrosine kinase inhibitors. It is used to treat many types of cancer, including advanced renal cell carcinoma, thyroid cancer, and hepatocellular carcinoma.

Because cabozantinib has not yet obtained marketing approval in China, domestic patients cannot directly purchase this drug locally. However, they can obtain cabozantinib through overseas channels, which include both original and generic versions of the drug. Original research and development drugs are usually priced higher. For example, in Japan and Europe, the price of such drugs may reach the level of 30,000 to 40,000 yuan. In comparison, the price of generic drugs appears to be more affordable. For example, the price range of generic drugs from places such as Laos, India and Bangladesh ranges from a few hundred to several thousand yuan. It is worth noting that the ingredients of these original drugs and generic drugs are almost the same. Therefore, patients can choose the drug that suits them according to their financial situation and disease needs.

As a targeted therapy drug, cabozantinib’s mechanism of action is mainly by inhibiting multiple key signaling pathways, thereby inhibiting the growth, spread and angiogenesis of cancer cells. Cabozantinib mainly acts on multiple receptor tyrosine kinases (RTKs), including MET (hepatocyte growth factor receptor), VEGFR (vascular endothelial growth factor receptor) , RET (rearranged oncogene family receptor kinase), KIT (cytoplasmic tyrosine kinase) and AXL (axon-associated protein kinase), etc. By inhibiting the activity of these receptor tyrosine kinases, cabozantinib can effectively block the growth signaling of tumor cells, thereby inhibiting the growth and metastasis of tumor cells.

In addition to acting on the tumor cells themselves, cabozantinib can also inhibit the vascular endothelial growth factor (VEGF) signaling pathway, thereby inhibiting the formation of new blood vessels in the tumor, reducing the blood supply to the tumor, and thereby inhibiting tumor growth and metastasis.

In general, cabozantinib is a targeted therapy that inhibits tumor cell growth and angiogenesis through multiple signaling pathways. It has shown good efficacy in treating many types of cancer and provides new treatment options for some patients with advanced cancer. However, patients need to closely follow their doctor's instructions when using cabozantinib and promptly report any adverse reactions to ensure optimal treatment effects.